Methods For Enhancing Efficacy Of A Vaccine By Administering An Il-4R Antagonist

Patent No. EP3416685 (titled "Methods For Enhancing Efficacy Of A Vaccine By Administering An Il-4R Antagonist") was filed by Regeneron Pharmaceuticals on Feb 17, 2017. The application was issued on Jun 26, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HAMPTON KNOWLESMar 25, 2025D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3416685

REGENERON PHARMACEUTICALS
Application Number
EP17708398A
Filing Date
Feb 17, 2017
Status
Revoked
Nov 7, 2025
Publication Date
Jun 26, 2024